Diaceutics PLC
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which d… Read more
Market Cap & Net Worth: Diaceutics PLC (DIUXF)
Diaceutics PLC (PINK:DIUXF) has a market capitalization of $115.71 Million ($115.71 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #19928 globally and #7281 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Diaceutics PLC's stock price $1.37 by its total outstanding shares 84629450 (84.63 Million).
Diaceutics PLC Market Cap History: 2020 to 2025
Diaceutics PLC's market capitalization history from 2020 to 2025. Data shows change from $129.11 Million to $115.71 Million (-6.61% CAGR).
Diaceutics PLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Diaceutics PLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.60x
Diaceutics PLC's market cap is 3.60 times its annual revenue
1.54x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $129.11 Million | $12.70 Million | $263.00K | 10.17x | 490.92x |
| 2021 | $114.20 Million | $13.94 Million | $561.00K | 8.19x | 203.56x |
| 2022 | $94.78 Million | $19.50 Million | $724.00K | 4.86x | 130.92x |
| 2023 | $115.71 Million | $23.70 Million | -$1.75 Million | 4.88x | N/A |
| 2024 | $115.71 Million | $32.16 Million | -$1.70 Million | 3.60x | N/A |
Competitor Companies of DIUXF by Market Capitalization
Companies near Diaceutics PLC in the global market cap rankings as of March 19, 2026.
Key companies related to Diaceutics PLC by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #724 globally with a market cap of $28.17 Billion USD.
- BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ:BTSGU): Ranked #989 globally with a market cap of $19.86 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2240 globally with a market cap of $6.77 Billion USD.
- HealthEquity Inc (NASDAQ:HQY): Ranked #2273 globally with a market cap of $6.65 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #724 | Veeva Systems Inc Class A | NYSE:VEEV | $28.17 Billion | $186.70 |
| #989 | BrightSpring Health Services, Inc. Tangible Equity Unit | NASDAQ:BTSGU | $19.86 Billion | $139.72 |
| #2240 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $6.77 Billion | $42.10 |
| #2273 | HealthEquity Inc | NASDAQ:HQY | $6.65 Billion | $79.40 |
Diaceutics PLC Historical Marketcap From 2020 to 2025
Between 2020 and today, Diaceutics PLC's market cap moved from $129.11 Million to $ 115.71 Million, with a yearly change of -6.61%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $115.71 Million | 0.00% |
| 2024 | $115.71 Million | 0.00% |
| 2023 | $115.71 Million | +22.07% |
| 2022 | $94.78 Million | -17.00% |
| 2021 | $114.20 Million | -11.55% |
| 2020 | $129.11 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Diaceutics PLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $115.71 Million USD |
| MoneyControl | $115.71 Million USD |
| MarketWatch | $115.71 Million USD |
| marketcap.company | $115.71 Million USD |
| Reuters | $115.71 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.